The leading DPP-4 inhibitor market worth of KRW 260 billion has been fueled again

The DPP-4 inhibitor-type diabetes treatment market has been fueled again.

Although 6 products have been competing in the market, Handok, which has shown its capacity in the diabetes market, also, entered the market and started to actively promote ‘Tenelia(generic name: teneligliptin).’

The DPP-4 inhibitor market is a market leading the current diabetes market, which has led the entire oral dr...